Log in

Relevant bibliographies by topics / Treatment outcome / Journal articles

Journal articles on the topic 'Treatment outcome'

To see the other types of publications on this topic, follow the link: Treatment outcome.

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Treatment outcome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Bloom, Bernard L. "Brief Interventions for Anxiety Disorders: Clinical Outcome Studies." Brief Treatment and Crisis Intervention 2, no. 4 (December 1, 2002): 325–40. http://dx.doi.org/10.1093/brief-treatment/2.4.325.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bloom, Bernard L. "Brief Psychotherapy With Children and Adolescents: Recent Treatment Outcome Studies." Brief Treatment and Crisis Intervention 2, no. 3 (September 1, 2002): 261–74. http://dx.doi.org/10.1093/brief-treatment/2.3.261.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ammini, Ariachery, Saptarshi Bhattacharya, Jaya Praksh Sahoo, Jim Philip, Nikhil Tandon, Ravinder Goswami, Viveka Jyotsna, et al. "Cushing's disease: Results of treatment and factors affecting outcome." HORMONES 10, no. 3 (July 15, 2011): 222–29. http://dx.doi.org/10.14310/horm.2002.1312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Legrand, C., R. Sylvester, L. Duchateau, P. Janssen, and P. Therasse. "Treatment outcome studies." European Journal of Cancer 38, no. 9 (June 2002): 1173–80. http://dx.doi.org/10.1016/s0959-8049(02)00085-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Alemi, Farrokh, Richard C. Stephens, Shirley Llorens, and Benjamin Orris. "A Review of Factors Affecting Treatment Outcomes: Expected Treatment Outcome Scale." American Journal of Drug and Alcohol Abuse 21, no. 4 (January 1995): 483–509. http://dx.doi.org/10.3109/00952999509002712.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bloom, Bernard L. "Planned Short‐Term Psychotherapy for Depression: Recent Controlled Outcome Studies." Brief Treatment and Crisis Intervention 1, no. 2 (September 1, 2001): 169–89. http://dx.doi.org/10.1093/brief-treatment/1.2.169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hørsted-Bindslev, Preben, and Henrik Løvschall. "Treatment outcome of vital pulp treatment." Endodontic Topics 2, no. 1 (July 2002): 24–34. http://dx.doi.org/10.1034/j.1601-1546.2002.20103.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Graber, T. M. "Orthodontics: Treatment Need and Treatment Outcome." American Journal of Orthodontics and Dentofacial Orthopedics 113, no. 2 (February 1998): A1. http://dx.doi.org/10.1016/s0889-5406(98)70152-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Malhotra, Parveen, Vani Malhotra, Yogesh Sanwariya, Ajay Chugh, Isha Pahuja, and Akshay Akshay. "Acute HBV Related ALF- Successful Outcome with Oral Antiviral Treatment." Clinical Research and Clinical Trials 5, no. 1 (January 7, 2022): 01–03. http://dx.doi.org/10.31579/2693-4779/069.

Full text

Abstract:

Case report: We present a young female of fourteen years who was admitted to the hospital with short duration of Icterus, malaise, vomiting and diagnosed to be having acute hepatitis B. She went into acute liver failure as evidenced by development of hepatic encephalopathy and coagulopathy. She was managed on lines of hepatic encephalopathy along with oral antiviral treatment. She recovered successfully and was discharged after two weeks in heamodynamically stable condition. After a gap of six months, she became Hepatitis B surface (HbsAg) & hepatitis B e-antigen (HbeAg) negative and Hepatitis B Virus DNA (HBV DNA) was undetectable with normal liver function tests. She is on regular follow up for last one year and is absolutely normal. Conclusion: Acute hepatitis B can go into acute liver failure in 1% of cases, treatment for which includes liver transplantation and oral antiviral treatment which is especially helpful in cases who cannot afford liver transplantation, as was in our case.

APA, Harvard, Vancouver, ISO, and other styles

10

Schlesinger, Michael H., Ilene F. Wilets, and Harris M. Nagler. "TREATMENT OUTCOME AFTER VARICOCELECTOMY." Urologic Clinics of North America 21, no. 3 (August 1994): 517–29. http://dx.doi.org/10.1016/s0094-0143(21)00624-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Tabata, Takahisa, Takuro Kitamura, Nobusuke Hohchi, Yasuhiro Kise, Rintaro Kawaguchi, Fumiko Takenaga, and Hideaki Suzuki. "Treatment Outcome of Myringoplasty." Practica Oto-Rhino-Laryngologica 110, no. 9 (2017): 593–97. http://dx.doi.org/10.5631/jibirin.110.593.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Gossop, M. "Addiction: Treatment and Outcome." Journal of the Royal Society of Medicine 85, no. 8 (August 1992): 469–72. http://dx.doi.org/10.1177/014107689208500815.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Tabata, Takahisa, Takuro Kitamura, Nobusuke Hohchi, Yasuhiro Kise, Rintaro Kawaguchi, Fumiko Takenaga, and Hideaki Suzuki. "Treatment Outcome of Myringoplasty." Practica oto-rhino-laryngologica. Suppl. 152 (2018): 22–23. http://dx.doi.org/10.5631/jibirinsuppl.152.22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Keane, Aida. "Narratives of Treatment Outcome." Journal of Constructivist Psychology 29, no. 4 (February 24, 2016): 382–95. http://dx.doi.org/10.1080/10720537.2015.1134365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Pratt, Sarah I. "Introduction to Treatment Outcome." Residential Treatment For Children & Youth 13, no. 4 (July 25, 1996): 1–27. http://dx.doi.org/10.1300/j007v13n04_01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

HAVENS, LESTON, and MEREDITH FIELDS. "Schizophrenia: Treatment, Process, Outcome." American Journal of Psychiatry 147, no. 2 (February 1990): 248. http://dx.doi.org/10.1176/ajp.147.2.248.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Blotcky, Mark J., and Thomas L. Dimperio. "Outcome of Inpatient Treatment." Journal of the American Academy of Child & Adolescent Psychiatry 30, no. 3 (May 1991): 507. http://dx.doi.org/10.1097/00004583-199105000-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Mirin, Steven M., and M. Jo Namerow. "Why Study Treatment Outcome?" Psychiatric Services 42, no. 10 (October 1991): 1007–13. http://dx.doi.org/10.1176/ps.42.10.1007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hastings, Margaret. "Outcome for Stroke Treatment." Physiotherapy 80, no. 9 (September 1994): 649. http://dx.doi.org/10.1016/s0031-9406(10)60902-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Holland, Katherine D., and Elaine Wyllie. "Outcome after surgical treatment." Neurosurgery Clinics of North America 13, no. 1 (January 2002): 135–44. http://dx.doi.org/10.1016/s1042-3680(02)80013-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pancherz, Hans. "Treatment timing and outcome." American Journal of Orthodontics and Dentofacial Orthopedics 121, no. 6 (June 2002): 559. http://dx.doi.org/10.1067/mod.2002.124165.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Wilson, G. Terence. "Treatment outcome in Bulimia." Advances in Behaviour Research and Therapy 11, no. 3 (January 1989): 161–74. http://dx.doi.org/10.1016/0146-6402(89)90020-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Kvittingen, E. A. "Tyrosinaemia ? treatment and outcome." Journal of Inherited Metabolic Disease 18, no. 4 (1995): 375–79. http://dx.doi.org/10.1007/bf00710049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rogers, Richard. "Treatability and treatment outcome." Behavioral Sciences & the Law 6, no. 4 (1988): 441–42. http://dx.doi.org/10.1002/bsl.2370060402.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Beutler, Larry E., Rudolf H. Moos, and Geoffrey Lane. "Coping, treatment planning, and treatment outcome: Discussion." Journal of Clinical Psychology 59, no. 10 (2003): 1151–67. http://dx.doi.org/10.1002/jclp.10216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

P, Dr Veena. "Fungal Keratitis – Epidemiology and Treatment Outcome - In North Costal Andhra Pradesh." Journal of Medical Science And clinical Research 05, no. 05 (May 6, 2017): 21486–97. http://dx.doi.org/10.18535/jmscr/v5i5.43.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Sanislow, Charles A., and Thomas H. McGlashan. "Treatment Outcome of Personality Disorders." Canadian Journal of Psychiatry 43, no. 3 (April 1998): 237–50. http://dx.doi.org/10.1177/070674379804300302.

Full text

Abstract:

Objective: To review the treatment outcome of personality disorders. Method: A literature search of studies pertaining to personality disorder and outcome was conducted, and studies that focused primarily on Axis II were retained. Of these, naturalistic outcome studies were distinguished from those that addressed treatment outcome specifically. The treatment outcome studies were examined in terms of type of treatment intervention, dependent variables, and outcome. Results: Contrary to contemporary assumptions about Axis II, a substantial number of treatment outcome studies were identified. Trends in the assumptions underlying psychosocial and pharmacologic approaches were identified on the basis of dependent variables. Conclusion: There is evidence that effective treatments exist to alleviate symptoms and reduce symptomatic behaviours that accompany personality disorders. What these results hold for the idea of remission from personality disorder is considered.

APA, Harvard, Vancouver, ISO, and other styles

28

Felling, Ryan J., Sahar M. A. Hassanein, Jennifer Armstrong, Luis Aversa, Lori Billinghurst, Neil A. Goldenberg, Jo Ellen Lee, Emily C. Maxwell, Michael J. Noetzel, and Warren Lo. "Treatment and outcome of childhood cerebral sinovenous thrombosis." Neurology: Clinical Practice 10, no. 3 (September 12, 2019): 232–44. http://dx.doi.org/10.1212/cpj.0000000000000720.

Full text

Abstract:

ObjectiveTo test our hypothesis that anticoagulation is associated with better neurologic outcomes in childhood cerebral sinovenous thrombosis (CSVT), we analyzed treatment and outcomes in a population of 410 children from the International Pediatric Stroke Study (IPSS).MethodsWe included patients enrolled in the IPSS registry with a diagnosis of CSVT at age >28 days with radiologic confirmation, in isolation or with concomitant arterial ischemic stroke. The primary outcome was the neurologic status at discharge. We defined unfavorable outcome as severe neurologic impairment or death at discharge. The Pediatric Stroke Outcome Measure was used for long-term outcome in those with follow-up. Predictors of anticoagulation use and outcome were analyzed by logistic regression.ResultsMost children (95%) had identifiable risk factors, and 82% received anticoagulation. Shift analysis demonstrated better outcomes at discharge in children who were anticoagulated, and this persisted with longer-term outcomes. In multivariable analysis, anticoagulation was significantly associated with favorable outcomes (adjusted odds ratio [aOR] unfavorable 0.32, p = 0.007) whereas infarct was associated with unfavorable outcome (aOR unfavorable 6.71, p < 0.001). The trauma/intracranial surgery was associated with a lower odds of anticoagulation use (aOR 0.14, p < 0.001).ConclusionsWithin the IPSS registry, children with risk factors of trauma or intracranial surgery were less likely to receive anticoagulation for CSVT. Anticoagulation was associated with a lower odds of severe neurologic impairment or death at hospital discharge, but this finding is limited and needs further confirmation in randomized, controlled, prospective studies.

APA, Harvard, Vancouver, ISO, and other styles

29

Harrison, Patricia A., and Stephen E. Asche. "Adolescent Treatment for Substance Use Disorders: Outcomes and Outcome Predictors." Journal of Child & Adolescent Substance Abuse 11, no. 2 (December 2001): 1–17. http://dx.doi.org/10.1300/j029v11n02_01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Taylor, Rachael W., Lindsey Marwood, Ben Greer, Rebecca Strawbridge, and Anthony J. Cleare. "Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review." Journal of Psychopharmacology 33, no. 11 (September 17, 2019): 1323–39. http://dx.doi.org/10.1177/0269881119872194.

Full text

Abstract:

Background: Treatment-resistant depression is an important contributor to the global burden of depression. Antidepressant augmentation is a recommended treatment strategy for treatment-resistant patients, but outcomes remain poor. Identifying factors that are predictive of response to augmentation treatments may improve outcomes. Aims: This review aimed to synthesise the existing literature examining predictors of response to augmentation treatments in patients who had insufficiently responded to initial treatment. Methods: A systematic search was conducted identifying 2241 unique manuscripts. 24 examining predictors of outcome to pharmacological or psychological augmentation treatment were included in this review. Results: Atypical antipsychotics were the most frequently assessed treatment class (nine studies), closely followed by mood stabilisers (eight studies). Only one eligible psychological augmentation study was identified. Early response to treatment (week 2) was the best-supported predictor of subsequent treatment outcome, reported by six studies. Many predictor variables were only assessed by one report and others such as pre-treatment severity yielded contradictory results, both within and across treatment classes. Conclusions: This review highlights the importance of early response as a predictor of pharmacological augmentation outcome, with implications for both the monitoring and treatment of resistant unipolar patients. Further replication is needed across specific interventions to fully assess the generalisability of this finding. However, the clear lack of consistent evidence for other predictive factors both within and across treatments, and the scarce examination of psychological augmentation, demonstrates the need for much more research of a high quality if response prediction is to improve outcomes for patients with treatment-resistant depression.

APA, Harvard, Vancouver, ISO, and other styles

31

Simpson, D. Dwayne, George W. Joe, and Barry S. Brown. "Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)." Psychology of Addictive Behaviors 11, no. 4 (December 1997): 294–307. http://dx.doi.org/10.1037/0893-164x.11.4.294.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Crandal, Brent R., Sharon L. Foster, Jason E. Chapman, Phillippe B. Cunningham, Patricia A. Brennan, and Elizabeth A. Whitmore. "Therapist perception of treatment outcome: Evaluating treatment outcomes among youth with antisocial behavior problems." Psychological Assessment 27, no. 2 (June 2015): 710–25. http://dx.doi.org/10.1037/a0038555.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ospel, JM, A. Ganesh, M. Kappelhof, R. McDonough, R. Nogueira, R. McTaggart, B. Menon, et al. "P.136 Evaluating outcome prediction models in endovascular treatment for acute ischemic stroke using baseline, treatment and post-treatment variables." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 48, s3 (November 2021): S58. http://dx.doi.org/10.1017/cjn.2021.412.

Full text

Abstract:

Background: Predicting outcomes after endovascular treatment (EVT) for acute ischemic stroke with baseline variables remains a challenge. We assessed the performance of stroke outcome prediction models for EVT in acute ischemic stroke in an iterative fashion using baseline, treatment-related and post-treatment variables. Methods: Data from the ESCAPE-NA1 trial were used to build 4 outcome prediction models using multi-variable logistic regression: Model 1 included baseline variables only that are available prior to treatment decision-making, model 2 included additional treatment-related variables, model 3 additional early post-treatment variables, and model 4 additional late post-treatment variables. The primary outcome was 90-day modified Rankin Scale score 0-2. Model performance was compared using the area under the curve (AUC). Results: Among 1,105 patients, good outcome was achieved by 666 (60.3%). When using baseline variables only (model 1), the AUC was 0.74 (95%CI:0.71-0.77); this iteratively improved when treatment and post-treatment variables were added to the models (model 2: AUC 0.77,95%CI: 0.74-0.80, model 3: AUC 0.80,95%CI:0.77-0.83, model 4: AUC 0.82, 95%CI:0.79-0.85). Conclusions: Predicting EVT outcomes using baseline variables alone is inaccurate in one in four patients, and may be inappropriate for patient selection. Even the most comprehensive models with treatment-related and post-treatment factors involve considerable uncertainty.

APA, Harvard, Vancouver, ISO, and other styles

34

Stimmel, Glen L. "Maximizing Treatment Outcome in Depression." Disease Management and Health Outcomes 9, no. 4 (2001): 179–86. http://dx.doi.org/10.2165/00115677-200109040-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Lind, E., O. Fausa, E. Gjone, and S. B. Mogensen. "Crohn's Disease: Treatment and Outcome." Scandinavian Journal of Gastroenterology 20, no. 8 (January 1985): 1014–18. http://dx.doi.org/10.3109/00365528509088864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ohbu, Sadayoshi. "Re-examination of Treatment Outcome." Nihon Naika Gakkai Zasshi 96, no. 6 (2007): 1247–48. http://dx.doi.org/10.2169/naika.96.1247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Mohammad, Akikur, Kristopher J. Irizarry, Rebecca Ninah Shub, and Alexandria Sarkar. "Addiction Treatment Aftercare Outcome Study." Open Journal of Psychiatry 07, no. 01 (2017): 51–60. http://dx.doi.org/10.4236/ojpsych.2017.71005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Gaikwad, Deepali, S. S. Gaikwad, and Snigdha Thakur. "Treatment outcome of tuberculous lymphadeniti." International Journal of Recent Scientific Research 8, no. 03 (March 28, 2017): 15809–12. http://dx.doi.org/10.24327/ijrsr.2017.0803.0008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Iványi, János László, Éva Marton, and Márk Plander. "Treatment outcome of immune thrombocytopenia." Orvosi Hetilap 153, no. 41 (October 2012): 1613–21. http://dx.doi.org/10.1556/oh.2012.29456.

Full text

Abstract:

Introduction: Treatment of immune thrombocytopenia is sometimes difficult and needs personal setting. According to evidence-based guidelines, corticosteroids are suggested for first-line treatment. In case of corticosteroid ineffectiveness, second-line therapeutic options (splenectomy, immunosuppressive drugs and, recently, thrombopoietin-mimetics) may result in beneficial therapeutic effect. Aims: The aim of the authors was to examine the clinicopathological data, disease course, treatment results, and the effectiveness of novel drugs in patients with immune thrombocytopenia. Patients and methods: The authors retrospectively analysed the files of 79 immune thrombocytopenic patients (26 males and 53 females) diagnosed and treated at the hematologic in- and outpatient units of the Markusovszky Hospital, County Vas, Hungary between January 1, 2000 and December 31, 2011. Remission rates, disease-free and overall survivals in response to corticosteroids (first-line treatment), after splenectomy (in cases when corticosteroids proved to be ineffective) and following second-line treatment were analysed. Survival curves were constructed using statistical software programs. Results: Of the 79 patients during a median follow-up of 66 months (min. 3, max. 144 months), 28 patients receiving first-line corticosteroids achieved complete remission and remained in a prolonged disease-free condition (35.4%; median disease-free survival 75.5 months; min. 2, max. 140 months). Thirty-eight patients underwent splenectomy after ineffective treatment with corticosteroids or other immunosuppressive (48.0%; median disease-free survival 94.2 months; min. 6, max. 136 months). Surgical complications occurred in 2 cases, while postoperative and late infections were absent. Five patients died but death was not related to immune thrombocytemia. Second-line treatment was applied in 13 patients (16.4%) and among these patients relapse of immune thrombocytopenia after splenectomy was observed in 6 patients. Favourable effects of both conventional (immunosuppressive) and novel treatments (rituximab, thrombopoietin-mimetics) were also detected. Conclusions: More than two-thirds of patients with immune thrombocytopenia responded to corticosteroids or to splenectomy and achieved prolonged disease-free remission. Novel drugs (rituximab, thrombopoietin-mimetics) applied only in few cases produced also favourable results in patients not responding to corticosteroids and splenectomy. Orv. Hetil., 2012, 153, 1613–1621.

APA, Harvard, Vancouver, ISO, and other styles

40

Pan, Ay-Woan, and Li-Ting Liu. "Therapeutic Relationship and Treatment Outcome." American Journal of Occupational Therapy 70, no. 4_Supplement_1 (August 1, 2016): 7011510234p1. http://dx.doi.org/10.5014/ajot.2016.70s1-po7019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Feldmann, Ingalill. "Satisfaction with orthodontic treatment outcome." Angle Orthodontist 84, no. 4 (July 2014): 581–87. http://dx.doi.org/10.2319/093013-710.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Finlay, Andrew Y., and Kristian Reich. "Outcome assessment and treatment goals." Expert Review of Dermatology 3, sup1 (August 2008): S39—S40. http://dx.doi.org/10.1586/17469872.3.4s.s39.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Millichap, J. Gordon. "Congenital Toxoplasmosis: Treatment and Outcome." Pediatric Neurology Briefs 9, no. 1 (January 1, 1995): 7. http://dx.doi.org/10.15844/pedneurbriefs-9-1-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Mikhail, Sameh, and Tanios Bekaii-Saab. "RASmutations: impact on treatment outcome." Colorectal Cancer 2, no. 6 (December 2013): 525–34. http://dx.doi.org/10.2217/crc.13.63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Garg, Prashant, Umang Mathur, Sreedharan Athmanathan, and Gullapalli N. Rao. "Treatment Outcome of Moraxella Keratitis." Cornea 18, no. 2 (March 1999): 176. http://dx.doi.org/10.1097/00003226-199903000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Wan, Michelle, Reid Finlayson, and Arran Rowles. "Sexual Dependency Treatment Outcome Study." Sexual Addiction & Compulsivity 7, no. 3 (July 2000): 177–96. http://dx.doi.org/10.1080/10720160008400217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tijssen, J. G. P., H. J. J. Kerkkamp, J. W. Viersma, J. M. De Beijer, P. J. De Feijter, and J. Lubsen. "Treatment, observations, and outcome events." European Heart Journal 8, suppl H (October 2, 1987): 35–48. http://dx.doi.org/10.1093/eurheartj/8.suppl_h.35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ozaki, T., M. Hamada, S. Sugihara, T. Kunisada, S. Mitani, and H. Inoue. "Treatment Outcome of Osteofibrous Dysplasia." Journal of Pediatric Orthopaedics B 7, no. 3 (July 1998): 199–202. http://dx.doi.org/10.1097/01202412-199807000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Rovet, Joanne. "Congenital hypothyroidism: treatment and outcome." Current Opinion in Endocrinology & Diabetes 12, no. 1 (February 2005): 42–52. http://dx.doi.org/10.1097/01.med.0000152669.91427.73.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Fouda, Mona. "MAXILLARY SINUS CARCINOMA: TREATMENT OUTCOME." Research in Oncology 5, Issue 1-2 (January 1, 2009): 13–17. http://dx.doi.org/10.21608/resoncol.2009.401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!